Chimezie Metu (Sacramento Kings) with an alley oop vs the Washington Wizards, 04/14/2021
Chimezie Metu (Sacramento Kings) with an alley oop vs the Washington Wizards, 04/14/2021
New Delhi [India], May 6 (ANI): In one of the first communications sent to the newly sworn-in Mamata Banerjee government in West Bengal, the Centre has asked it to be part of PM-Kisan Samman Nidhi scheme and appoint officers to fast-track the process.
BANGKOK — Thailand sought Thursday to assure its foreign residents that they can get COVID-19 vaccinations, countering comments by some officials suggesting they would be at the end of the line for inoculations. Opas Karnkawinpong, director-general of Thailand's Department of Disease Control, made the pledge as Thailand fought to control an outbreak in the heart of its capital that has sickened thousands of people in the past month, Thais and foreigners alike. He said at least 70% of Thailand's population has to be inoculated to create “herd immunity” and that Prime Minister Prayut Chan-ocha “mentioned clearly that everyone on Thai soil, both Thais and foreigners, can access the vaccines.” “Foreigners and diplomats will have the same criteria as Thais," Opas said, adding that the country had a population of 67 million Thai nationals and 3 million foreigners. More than 2.5 million foreigners in Thailand are from neighbouring countries, including Cambodia, Laos and Myanmar. Many work on construction sites and in factories. The rest, about 200,000, are mostly professionals legally living in Thailand and retirees — from Australia, China, Britain, Europe, the United States and elsewhere. Opas’ comments came after some health authorities had said foreigners legally living in the country would have to wait until the entire Thai population was inoculated to get shots. With strict travel restrictions in place, many foreign residents would need to make time-consuming and expensive trips abroad to get the shots. “We have followed international practice," he said. “Thais and foreigners including diplomats will be treated equally. ” China's embassy in Thailand posted a statement on its website Thursday saying that Thai authorities recently agreed to vaccinate Chinese citizens beginning in late May as a gesture of friendship and co-operation against COVID-19, even though vaccine supplies are limited. Asked about the statement, Thai Foreign Ministry spokesman Tanee Sangrat said he was unaware of any specific plans for vaccinating Chinese residents. China has a policy of vaccinating its citizens abroad. There are an estimated 150,000 Chinese living in Thailand, the biggest group of foreigners aside from citizens of neighbouring Myanmar, Cambodia and Laos, who are generally migrant workers. Thailand has been very slow and haphazard in its vaccination rollout and showed no sense of urgency until early April, when new infections began sweeping through slums and low-income areas located in and around Bangkok’s central business district. Less than 2% of all Thais have been inoculated for COVID-19, mostly health workers, but the government says it intends to vaccinate 70% by the end of the year. Until recently, Thailand had relatively few cases and less than 100 deaths. It only signed deals for the local manufacturing of AstraZeneca vaccines in late 2020, choosing at first only to import China’s Sinovac vaccine. The effort gained urgency as new cases surged to about 2,000 a day and deaths began escalating. On Thursday, Thailand reported 1,911 new cases and 18 new deaths, bringing the total number of confirmed infections to 76,811, with 336 deaths. Of the total cases, 47,948 cases were since April 1, along with most deaths. Thailand closed its borders to almost all travellers for months last year and it has been requiring visitors to the country to present tests showing they are not positive for COVID-19 and spend up to 14 days in mandatory quarantines. The latest outbreaks are a big setback for plans to allow fully vaccinated foreign visitors to enter the country with no quarantine to help revive the devastated tourism industry. Nearly 40 million tourists visited Thailand in 2019, compared to almost none after the government ordered the airports closed to most international travel in April 2020. Critics of Thailand's handling of the crisis assert that local business interests played a role in delaying and limiting vaccination efforts. Only three vaccines have been authorized for use in Thailand and only two have been administered so far: the AstraZeneca and Sinovac vaccines. The government now says it is trying to import U.S. and Russian-made vaccines, but they likely face a lengthy authorization process. The Associated Press
One led the FBS with 328 carries and 2,094 rushing yards in 2019.
Kroll Bond Rating Agency (KBRA) assigns preliminary ratings to five classes of notes issued by Flagship Credit Auto Trust 2021-2 ("FCAT 2021-2"), an asset-backed securitization collateralized by a pool of auto loans.
RADNOR, Pa., May 06, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the Western District of Washington against CytoDyn Inc. (OTCMKTS: CYDY) (“CytoDyn”) on behalf of those who purchased or acquired CytoDyn common stock between March 27, 2020 and March 9, 2021, inclusive (the “Class Period”). Deadline Reminder: Investors who purchased or acquired CytoDyn common stock during the Class Period may, no later than May 17, 2021, seek to be appointed as a lead plaintiff representative of the class. For additional information or to learn how to participate in this litigation please contact Kessler Topaz Meltzer & Check, LLP: James Maro, Esq. (484) 270-1453 or Adrienne Bell, Esq. (484) 270-1435; toll free at (844) 887-9500; via e-mail at firstname.lastname@example.org; or click https://www.ktmc.com/cytodyn-class-action-lawsuit?utm_source=PR&utm_medium=link&utm_campaign=cytodyn CytoDyn is a biotechnology company that has focused on the development and commercialization of a drug named “Leronlimab” which has long been promoted as a potential therapy for HIV patients. Since the beginning of the global COVID-19 pandemic, CytoDyn began aggressively touting Leronlimab as a treatment for COVID-19. Following CytoDyn’s pivot to hyping Leronlimab as a treatment for COVID-19, CytoDyn’s stock price rose exponentially. The Class Period commences on March 27, 2020, when CytoDyn issued a press release regarding Leronlimab’s use in treating COVID-19 patients entitled “Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with Reduced Pulmonary Inflammation.” Throughout the Class Period, CytoDyn continued to tout Leronlimab as a potential treatment for COVID-19 and to pump up the stock price of CytoDyn while executives aggressively sold shares. Indeed, while CytoDyn’s stock price was sufficiently pumped with the COVID-19 cure hype, long-term shareholders, including defendants Nader Z. Pourhassan, CytoDyn’s Chief Executive Officer, and Michael Mulholland, CytoDyn’s Chief Financial Officer, dumped millions of shares. Following the cash-out by CytoDyn insiders and long-term shareholders, the defendants’ scheme began to unravel. On Friday, March 5, 2021 after the close of trading, and continuing over that weekend, CytoDyn issued press releases describing the results of the Phase IIb/III data on Leronlimab. The press releases had titles such as “Cytodyn to File Accelerated Rolling Review with MHRA and Interim Order (IO) with Health Canada for COVID-19” and “Cytodyn’s Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab.” However, hidden in the press releases was a disclosure that the primary endpoint of the study—lowering all-cause mortality at Day 28— was not statistically significant. Following the issuance of its press releases, CytoDyn was accused of “massaging the data” and squeezing good news out of a failed study, the results of which CytoDyn reportedly sat on pending regulatory discussions. Following the release of the data, the price of CytoDyn’s common stock fell over 28% to close at $2.91 on March 8, 2021. On March 9, 2021, the price of CytoDyn’s common stock continued to fall, dropping an additional 19% to close at $2.35. The complaint alleges that, throughout the Class Period, the defendants made false and/or misleading statements and/or failed to disclose that CytoDyn’s development and marketing of Leronlimab as a treatment for COVID-19 was not commercially viable. CytoDyn investors may, no later than May 17, 2021, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer & Check, LLP or other counsel, or may choose to do nothing and remain an absent class member. A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation. In order to be appointed as a lead plaintiff, the Court must determine that the class member’s claim is typical of the claims of other class members, and that the class member will adequately represent the class. Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff. Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). The complaint in this action was not filed by Kessler Topaz Meltzer & Check, LLP. For more information about Kessler Topaz Meltzer & Check, LLP please visit www.ktmc.com. CONTACT: Kessler Topaz Meltzer & Check, LLPJames Maro, Jr., Esq.Adrienne Bell, Esq.280 King of Prussia RoadRadnor, PA 19087(844) 887-9500 (toll free)email@example.com
The Duke and Duchess of Sussex have thanked royal fans for their support over the past two years.
The County of Simcoe and area partners will host another “Ask an Expert” virtual session for business owners that will be focused on Emergency Pre-paredness and Business Continuity. As the impact of a global pandemic has affected businesses and organizations and their ability to deliver goods and services, taking the time to develop a business continuity plan can help organizations identify vulnerabilities. Businesses can develop mitigation strategies and contingency plans in or-der to reduce the negative consequences of all types of emergencies. This online session will provide the knowledge and tools to help a business create a continuity plan as well as enhancing emergency preparedness among staff members. Experts who will be presenting at this virtual session include Rob Heffernan, Emergency Services Program Supervisor at the County of Simcoe. Mr. Heffernan delivers a range of emergency management training courses for staff at the County, local municipalities, and partner organizations. He works on the development and maintenance of the County’s Emergency Operations Centres and Emergency Response Plans, including the Continuity of Operations Plan. Also presenting will be Colleen Simpson, Manager of 911 and Emergency Planning for the County of Simcoe.Ms. Simpson has over 20 years experience in emergency services along with extensive knowledge in 911 and emergency management. The virtual seminar will take place May 6, from 2 – 3:30 p.m. Entrepreneurs, business owners, and organizational leaders are invited to attend. This is a free event but registration is required.To register, visit: www.askanexpert_businesscontinuity.eventbrite.ca. Brian Lockhart, Local Journalism Initiative Reporter, New Tecumseth Times
The "Ballast Water Treatment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to ResearchAndMarkets.com's offering.
LOS ANGELES, May 06, 2021 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. Investors suffering losses on their investments are encouraged to contact The Law Offices of Frank R. Cruz to discuss their legal rights in these class actions at 310-914-5007 or by email to firstname.lastname@example.org. Canaan Inc. (NASDAQ: CAN)Class Period: February 10, 2021 – April 9, 2021Lead Plaintiff Deadline: June 14, 2021 The complaint filed alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) Canaan had experienced significant ongoing supply chain disruptions during fourth quarter 2020 (“4Q20”); (2) the introduction of Canaan’s next-generation A12 series bitcoin mining machines had cannibalized sales of the older product offerings during the 4Q20; (3) as a result of the foregoing, Canaan’s 4Q20 sales and sales revenues had declined dramatically; and (4) as a result of the foregoing, Canaan was not on track to achieve the strong financial prospects it had led the market to believe. Franklin Wireless Corp. (NASDAQ: FKWL)Class Period: September 17, 2020 – April 8, 2021Lead Plaintiff Deadline: June 15, 2021 Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Franklin’s hotspot devices suffered from battery issues, including overheating, thereby presenting a fire hazard; (2) that, as a result, it was reasonably likely that the Company’s customers would recall Franklin’s devices; (3) that, as a result, Franklin would suffer reputational harm; and (4) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Intrusion Inc. (NASDAQ: INTZ)Class Period: January 13, 2021 – April 13, 2021Lead Plaintiff Deadline: June 15, 2021 Throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that Intrusion’s Shield product was merely a repackaging of existing technology in the Company’s portfolio; (2) that Shield lacked the patents, certifications, and insurance critical to the sale of cybersecurity products; (3) that the Company had overstated the efficacy of Shield’s purported ability to protect against cyberattacks; (4) that, as a result of the foregoing, Intrusion’s Shield was reasonably unlikely to generate significant revenue; and (5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis. Follow us for updates on Twitter: twitter.com/FRC_LAW. To be a member of these class actions, you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action. If you wish to learn more about these class actions, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Frank R. Cruz, of The Law Offices of Frank R. Cruz, 1999 Avenue of the Stars, Suite 1100, Los Angeles, California 90067 at 310-914-5007, by email to email@example.com, or visit our website at www.frankcruzlaw.com. If you inquire by email please include your mailing address, telephone number, and number of shares purchased. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Contacts The Law Offices of Frank R. Cruz, Los AngelesFrank R. Cruz, firstname.lastname@example.org
TORONTO — A finding that wine from the West Bank can be labelled as a product of Israel was not reasoned properly and should now be thrashed out again, the Federal Court of Appeal has ruled. As a result, the appellate court said the politically sensitive case, which at one point threatened to put Middle East politics on trial, should go back to the Complaints and Appeals Office of the Canadian Food Inspection Agency. "The administrative decision maker must demonstrate that its interpretation of the relevant provisions is consistent with their text, context and purpose," Chief Justice Marc Noel said. "Here this demonstration is totally lacking." The case arose in 2017, when Dr. David Kattenburg, of Winnipeg, raised concerns that wines produced by Psagot and Shiloh Winery, located in the West Bank, were from Israeli settlements in the occupied territories, not Israel itself. He argued the wines should not, under Canadian law, be branded as Product of Israel. The Canadian Food Inspection Agency initially sided with him. However, the agency reversed course after some Jewish groups protested and Global Affairs Canada said the West Bank could be considered Israeli territory under the Canada-Israel free trade agreement. In July 2019, a Federal Court judge found the settlements were not part of the State of Israel and the labelling was therefore misleading and deceptive. She sent the case back to the food inspection agency, saying Canadian consumers needed to know exactly what they were buying. "One peaceful way in which people can express their political views is through their purchasing decisions," then-judge Anne Mactavish wrote, prompting the federal government to appeal. In its analysis, the Federal Court of Appeal said the food agency was required to interpret and apply Canadian laws to decide whether the wine labels were indeed false or misleading. The view of Global Affairs that the West Bank falls under the Canada-Israel Free Trade Agreement played a "determinative role" in the food agency's decision that the labelling was legal, Noel said. However, that was not enough to decide whether the agency's ruling had been reasonable, he said. "We simply have no idea how the agency construed its legislation in coming to the conclusion that the labels are compliant," Noel said. Noel said the agency, in taking a fresh look at the case, will want to hear from the affected parties, including Psagot, which had been unaware of the case until it reached Federal Court. Noel also made it clear the agency is not bound by Mactavish's reasons. "It will be open to the agency, as the decider of the merits of the labelling issue, to come to whatever outcome it thinks appropriate, provided that its interpretation and application of the relevant provisions to the facts in issue can be seen to be reasonable," Noel said. Psagot bills itself as an award-winning winery 15 minutes north of Jerusalem. It says its wines are produced by Israelis under auspices of an Israeli company in an Israeli community subject to Israeli law in Israeli territory. "Put simply, Psagot Winery proudly produces wines that are products of Israel," it says. The winery said it was pleased the Federal Court of Appeal had now sent the case back to the food agency with direction the lower court's decision was not binding, and that Psagot can make submissions. Some Jewish groups called the ruling a victory, with one saying the case was "part of a broader campaign to boycott Israel and Israeli goods." This report by The Canadian Press was first published May 6, 2021. Colin Perkel, The Canadian Press
The mission marked the first time the Starship prototype didn't end up in flames
Jarvis Cocker, Maxine Peake and Bernardine Evaristo all oppose the government proposals.
When Americans log onto social media, they see a culture war fought in seemingly every post and thread.
Arria NLG today announced the latest release of their advanced Tableau dashboard extension, delivering augmented self-service analytics for immediate data understanding.
The site says it will "take enforcement action on accounts whose apparent intent is to replace or promote content affiliated with a suspended account.”
A B.C. couple have won more than $1 million in lottery money in less than a year after winning big in both Lotto 6/49 and the Set For Life scratch card game.
Idaho legislators will recess again and return to the longest in Idaho’s history at 122 days and counting.
Los Angeles, California--(Newsfile Corp. - May 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Emergent BioSolutions Inc. ("Emergent BioSolutions" or "the Company") (NYSE: EBS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between July 6, 2020 and March 31, ...
Los Angeles, California--(Newsfile Corp. - May 6, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pinterest, Inc. ("Pinterest" or "the Company") (NYSE: PINS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.Investors who purchased the Company's securities between February 4, 2021 and April 27, 2021, inclusive ...
A selective reduction in medical services in hospitals that was ordered to prepare for a possible increase in COVID-19 patients across Nova Scotia is already paying off at the Cape Breton Regional Hospital, the health authority says. Brett MacDougall, executive director of operations for the health authority's eastern zone, said the regional hospital normally has three in-patient beds set aside for people infected with the virus, but there are now four positive patients. The number of medical in-patient beds was able to expand right away, he said, due to the reduction of blood collections and some surgeries. "That's not something that we take lightly," he told CBC's Information Morning Cape Breton. "We've tried to plan week by week. We didn't go into a sort of a big-bang approach where we closed everything down." The hospital normally has two beds reserved in intensive care for COVID-19 patients, but those are not being used, yet, MacDougall said. The service reductions that started this week have helped the eastern zone handle a huge increase in testing for the virus and made beds and nurses available as the number of cases climbs across the province. Services not reduced indefinitely The reductions mean the zone is prepared to look after its own patients and can scale up to handle those from other zones, if that becomes necessary, he said. "We're being a bit more purposeful this time," he said. "We're going at it week by week or every two weeks, so that we're not saying, 'OK, this service is closed for the next indefinite period of time.'" The health authority postponed surgeries for two weeks at the Northside General Hospital in North Sydney and reduced planned surgical admissions at the regional hospital in Sydney from a normal high of 14 per day down to four, MacDougall said. St. Martha's Regional Hospital in Antigonish has one in-patient bed and one ICU bed available any time for COVID-positive patients, but selective service reductions mean those can also be expanded as needed, he said. That could include taking patients from other areas, MacDougall said. "Each zone is looking at what capabilities they may have to help respond to any other zone that may be in additional pressure in relation to either COVID in-patient capacity or COVID ICU capacity and/or normal operations," he said. That usually happens anyway, but with the vast majority of cases occurring in the central zone, that practice is increasingly important. On Wednesday, the government announced 175 new cases, with 149 of those in the central zone. "We do try and extend ourselves out and help other areas and other regions across the province, but particularly now, with increased activity, there could be requests from central zone for us to assist them and we would be happy to help them." MORE TOP STORIES